Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction
Raffaele Altara, Mauro Giordano, Einar Sjaastad Nordén, et al.
Frontiers in Endocrinology (2017) Vol. 8
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Epicardial Adipose Tissue May Mediate Deleterious Effects of Obesity and Inflammation on the Myocardium
Milton Packer
Journal of the American College of Cardiology (2018) Vol. 71, Iss. 20, pp. 2360-2372
Closed Access | Times Cited: 477
Leptin-Aldosterone-Neprilysin Axis
Milton Packer
Circulation (2018) Vol. 137, Iss. 15, pp. 1614-1631
Open Access | Times Cited: 196
Heart failure in diabetes
Stanislovas S. Jankauskas, Urna Kansakar, Fahimeh Varzideh, et al.
Metabolism (2021) Vol. 125, pp. 154910-154910
Open Access | Times Cited: 137
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Javed Butler, Sanjiv J. Shah, Mark C. Petrie, et al.
The Lancet (2024) Vol. 403, Iss. 10437, pp. 1635-1648
Open Access | Times Cited: 136
Role of Leptin in Cardiovascular Diseases
Mareike S. Poetsch, Anna Strano, Kaomei Guan
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 137
Obesity-Related Heart Failure With a Preserved Ejection Fraction
Milton Packer, Dalane W. Kitzman
JACC Heart Failure (2018) Vol. 6, Iss. 8, pp. 633-639
Open Access | Times Cited: 135
Conflicting vascular and metabolic impact of the IL-33/sST2 axis
Raffaele Altara, Rana Ghali, Ziad Mallat, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 12, pp. 1578-1594
Open Access | Times Cited: 114
Do sodium‐glucose co‐transporter‐2 inhibitors prevent heart failure with a preserved ejection fraction by counterbalancing the effects of leptin? A novel hypothesis
Milton Packer
Diabetes Obesity and Metabolism (2018) Vol. 20, Iss. 6, pp. 1361-1366
Closed Access | Times Cited: 94
Epicardial Adipose Tissue and Cardiovascular Disease
Thierry H. Le Jemtel, Rohan Samson, Karnika Ayinapudi, et al.
Current Hypertension Reports (2019) Vol. 21, Iss. 5
Closed Access | Times Cited: 77
Heart Failure With Preserved Ejection Fraction in Diabetes: Mechanisms and Management
Patrick Meagher, Mohamed Adam, Robert Civitarese, et al.
Canadian Journal of Cardiology (2018) Vol. 34, Iss. 5, pp. 632-643
Closed Access | Times Cited: 64
New Mechanisms to Prevent Heart Failure with Preserved Ejection Fraction Using Glucagon-like Peptide-1 Receptor Agonism (GLP-1 RA) in Metabolic Syndrome and in Type 2 Diabetes: A Review
Jorge Jalil, Luigi Gabrielli, María Paz Ocaranza, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4407-4407
Open Access | Times Cited: 8
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Monika Rech, Arantxa Barandiarán Aizpurua, Vanessa van Empel, et al.
Cardiovascular Research (2018) Vol. 114, Iss. 6, pp. 782-793
Closed Access | Times Cited: 51
Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction
Isabel T. N. Nguyen, Maarten M. Brandt, Jens van de Wouw, et al.
PLoS ONE (2020) Vol. 15, Iss. 5, pp. e0232399-e0232399
Open Access | Times Cited: 38
HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of Atrial Fibrillation
Milton Packer
JACC Heart Failure (2019) Vol. 8, Iss. 1, pp. 35-42
Open Access | Times Cited: 30
Augmentation of glucagon‐like peptide‐1 receptor signalling by neprilysin inhibition: potential implications for patients with heart failure
Milton Packer
European Journal of Heart Failure (2018) Vol. 20, Iss. 6, pp. 973-977
Open Access | Times Cited: 29
Overlapping pathogenic signalling pathways and biomarkers in preeclampsia and cardiovascular disease
Sonja Šuvakov, Emma Bonner, Valentina Nikolić, et al.
Pregnancy Hypertension (2020) Vol. 20, pp. 131-136
Open Access | Times Cited: 25
Early cardiac-chamber-specific fingerprints in heart failure with preserved ejection fraction detected by FTIR and Raman spectroscopic techniques
Niki Tombolesi, Raffaele Altara, Gustavo José Justo da Silva, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 14
Gasotransmitter signaling in energy homeostasis and metabolic disorders
Amr Ali, Yuehong Wang, Lingyun Wu, et al.
Free Radical Research (2020) Vol. 55, Iss. 1, pp. 83-105
Closed Access | Times Cited: 22
Genomic, Proteomic, and Metabolic Comparisons of Small Animal Models of Heart Failure With Preserved Ejection Fraction: A Tale of Mice, Rats, and Cats
Alex Smith, Raffaele Altara, Ghadir Amin, et al.
Journal of the American Heart Association (2022) Vol. 11, Iss. 15
Open Access | Times Cited: 14
A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities
Géraldine Hubesch, Aliénor Hanthazi, Angela Acheampong, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 8
Open Access | Times Cited: 12
Deficit of resolution receptor magnifies inflammatory leukocyte directed cardiorenal and endothelial dysfunction with signs of cardiomyopathy of obesity
Bochra Tourki, Vasundhara Kain, Saame Raza Shaikh, et al.
The FASEB Journal (2020) Vol. 34, Iss. 8, pp. 10560-10573
Open Access | Times Cited: 18
Diabetes Mellitus and Heart Failure With Preserved Ejection Fraction: Role of Obesity
Aneesh Dhorepatil, Tariq Thannoun, Rohan Samson, et al.
Frontiers in Physiology (2022) Vol. 12
Open Access | Times Cited: 10
Upregulation of Myocardial and Vascular Phosphodiesterase 9A in A Model of Atherosclerotic Cardiovascular Disease
Dániel Priksz, Mariann Bombicz, Balázs Varga, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 10, pp. 2882-2882
Open Access | Times Cited: 17
Negative synergism of diabetes mellitus and obesity in patients with heart failure with preserved ejection fraction: a cardiovascular magnetic resonance study
Selçuk Küçükseymen, Ulf Neisius, Jennifer Rodriguez, et al.
The International Journal of Cardiovascular Imaging (2020) Vol. 36, Iss. 10, pp. 2027-2038
Closed Access | Times Cited: 16
Therapeutic Stalemate in Heart Failure With Preserved Ejection Fraction
Rohan Samson, Thierry H. Le Jemtel
Journal of the American Heart Association (2021) Vol. 10, Iss. 12
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top